clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Precision Medicine
Liquid Biopsy Developer Karius Completes $165M Series B Financing
Translational Research
Molecular Mechanisms of Osteosarcoma Provide Clues for Improved Immunotherapy Strategies
Precision Medicine
FDA Releases List of Genetic Variants Known to Affect Existing Drug…
Molecular Dx
Co-Diagnostics Seeks CE Mark for its COVID-19 Coronavirus Test
Translational Research
Researchers Discover Molecular Pathway Involved in Immunotherapy Response
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Precision Medicine
Liquid Biopsy Developer Karius Completes $165M Series B Financing
New Products
Esophageal DNA Test for Barrett’s Esophagus
Translational Research
Molecular Mechanisms of Osteosarcoma Provide Clues for Improved Immunotherapy Strategies
Precision Medicine
FDA Releases List of Genetic Variants Known to Affect Existing Drug…
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Multimedia
All
Webinars
eBooks
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Precision Medicine
Mainstreaming Precision Oncology
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Informatics
Bioinformatics
Bioinformatics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bioinformatics
Precision Oncology Company OncoDNA Closes $20M Series B Financing
February 14, 2020
Bioinformatics
Takeda Invests in Patient-Centric Health Data Company Seqster
February 13, 2020
Bioinformatics
Alzheimer’s Disease Development May Be Thwarted by Certain Gene Variants
February 5, 2020
Bioinformatics
102 New Autism Genes Mapped
February 5, 2020
Bioinformatics
Applying Predictive Modeling to Pneumococcal Vaccine Design Could Halve Disease Occurrence
February 4, 2020
Bioinformatics
LifeOmic to Deploy IU-based Healthy Breast Tissue Bank Data on the...
January 27, 2020
Bioinformatics
Genomic Database of More than 2,500 Healthy, Older Australians Released
January 24, 2020
Bioinformatics
Evotec, Indivumed Launch NSCLC Precision Medicine Collaboration
January 24, 2020
Bioinformatics
New Security Concerns about DTC Genetic Testing Raised
January 9, 2020
Bioinformatics
Taproot Health Launches National Oncology Database to Advance Precision Medicine
January 3, 2020
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1550-218x150.jpeg "Researchers Discover Molecular Pathway Involved in Immunotherapy Response")
![Bristol-Myers Squibb (BMS) plans to use Natera's Signatera custom circulating tumor DNA (ctDNA) assay in a Phase II study designed to assess the pharma giant’s cancer immunotherapy Opdivo (nivolumab) as an adjuvant treatment for non-small cell lung cancer (NSCLC). [Source: Eraxion/Getty]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1893-324x160.jpeg "Evotec, Indivumed Launch NSCLC Precision Medicine Collaboration")
